Background. IgA nephropathy (IgAN) is considered as a disease of young men under 30 years of age. Findings on clinical and histological presentation and outcome in older patients have rarely been published. Methods. In a prospective cohort of IgAN patients, recruited over 3 years, 33 patients over age 50 were compared to 96 patients under age 50, according to clinical and histological findings. Actuarial renal survival rate was studied after a mean post-biopsy followup of 41 months. Results. Both groups of patients were comparable at baseline for frequency of proteinuria, microscopic haematuria and gross haematuria, but older patients had a significantly higher incidence of hypertension (65 vs 24%, P<0.0l). Time between onset and diagnosis of IgAN was similar in both groups. Proteinuria/day, systolic blood pressure, and serum IgA levels were significantly higher, and C cr was significantly lower in the older patients at the time renal biopsy was performed, but serum creatinine and albumin were not. No difference was observed between the two groups for the presence of glomerular or tubulointerstitial lesions. Only endarteritis was significantly more common in older patients (75 vs 34%, P<0.0\). End-stage renal failure (ESRF) was confirmed in five patients over 50 and 17 under 50. Renal actuarial survival curves did not show any significant difference between the two groups, even though the six patients who died were classified as ESRF. Conclusions. When the histological diagnosis of IgAN was established, factors that carry a poor prognosis, i.e. proteinuria, high blood pressure, and decreased C CT were more commonly present in patients over 50 than under 50. However, after the completion of a relatively short follow-up period, renal survival was identical in the two study groups. Prolonged follow-up is necessary to confirm this trend.
Introduction
Since Berger first described idiopathic IgA mesangial nephropathy (IgAN) in 1968 [1] , this disease has been universally recognized as a disease affecting primarily young men under 30 years of age. In 1985, Abrass [2] considered that mesangial cell proliferative glomerulonephritis was relatively uncommon in the elderly. In 1991, Porush and Faubert [3] found only 36 patients over 60 with mesangial nephritis reported in the literature. They concluded that this disease appears to have a more unfavourable prognosis in the elderly.
However, few papers have been published specifically on IgAN in elderly subjects [4] . The role of age has been examined in many epidemiological studies [5] [6] [7] [8] [9] [10] [11] [12] , but since most were retrospective studies, conducted over long periods, with possible changes in renal biopsy policies, IgAN may not always have been detected in older patients. Thus to better evaluate the epidemiological features of IgAN after 50 years of age, we conducted a prospective and longitudinal study on patients with IgAN.
Subjects and methods
Diagnosis of IgAN was established if immunofluorescence studies revealed a predominance of IgA deposits in the mesangium of all glomeruli present in the biopsy, in patients without lupus erythematosus, cirrhosis and HenochSchonlein purpura. Between October 1988 and September 1991, we enrolled all adults over age 15 with evidence of IgAN in a prospective and longitudinal study. Almost all nephrologists and pathologists practicing in eastern France (17 Nephrology units) who perform and examine renal biopsies participated in this study. Consequently only a small number of IgAN may have escaped detection in this geographic area [13] .
Depending on age at the time of renal biopsy, we divided the patients into two groups: patients over 50 years of age (group 1) and those under 50 (group 2). Both groups were compared as follows:
Clinical evaluation included previous medical disorders, especially infection and neoplastic disease. Information on initial symptoms was recorded including episodes of gross haematuria, microscopic haematuria, proteinuria and hypertension. Time between onset of symptoms and renal biopsy was calculated.
Biochemical parameters were measured in each study centre's laboratory: proteinuria (g/24 h), total protein (g/1), albumin (g/1), C cr (ml/min), serum creatinine (umol/1), IgA level (g/1) (normal values, 0.9-3.3 g/1), C 3 (normal values, 0.55-1.05 g/1), C 4 (normal values, 0.15-0.30 g/1).
More detailed histological analysis was performed on 63 biopsy specimens (47 patients under age 50 and 16 over age 50). Glomerular lesions: mesangial cell proliferation, focal and segmental lesions, crescents, total obsolescence; tubular lesions: atrophy, necrosis; interstitial lesions: fibrosis, inflammation; vascular lesions: arteriolosclerosis, endarteritis, and distribution of other glomerular immunoglobulin deposits (IgG, IgM), complement components (C 3 , C 4 , C lq ), and fibrinogen were described as dichotomous variables, i.e. present/absent.
The zero time for the study was the day of the first renal biopsy. The observation period for all subjects was extended to December 1994. 
Results
One hundred and twenty-nine subjects met the inclusion criteria. At histological diagnosis, mean age of the study population was 38.4 years (range, 15-77) ( Figure 1 
consisted of 96 patients (78 males and 18 females). There was no difference in sex ratio before or after age 50 years. At baseline, the frequency of clinical and biochemical characteristics was similar in both groups of patients involving episodes of gross haematuria (43.7 vs 39.3%), microscopic haematuria (74.2 vs 82.4%), proteinuria (81.2 vs 78.7%). But hypertension was more frequent in group 1 than in group 2, i.e. 65.6 vs 24.4% (P<0.0l). Time between clinical presentation and renal biopsy was 4.2 ±1.4 years in group 1 and 3.9 + 0.6 years in group 2 (NS). Prevalence of previous serious infection was 18 .2% in group 1 and 14.5% in group 2 (NS). Four patients with neoplastic disease were identified in group 1 (12.1%) vs three in group 2 (3.1%) (P<0.02). In three patients with neoplastic disease, the diagnosis was established before renal biopsy was performed. In four patients it was confirmed afterward (mean with regard to zero time -1.1 year; range, -7 to +5). Neoplastic disease involved three adenocarcinomas (2 colon cancers and 1 prostate cancer), one laryngeal epithelioma, one lymphoma, one ovarian cystadenocarcinoma, and one mycosis fungoides.
At the time of biopsy, group 1 patients had significantly higher systolic blood pressure, more severe proteinuria, and higher IgA levels than patients in group 2 (Table 1) . C cr was significantly lower in group 1 than in group 2. No difference was observed between the two groups regarding the presence of glomerular or tubulointerstitial lesions and the distribution of immune deposits (Table 2 ). However, endarteritis was significantly more common in older than younger patients.
Data were obtained up to the time of death or renal death or up to December 1994 for 5291 patientmonths, out of a potential observation period of 6539 patient-months (81%). Mean post-biopsy follow-up was 41 months (range 0.9-75.7). It was similar in both groups (41.0 vs 41.0 months).
Six patients died before end-stage renal failure. Age at death was 77, 74, 68, 68, 65 and 41 years respectively. Causes of death were stroke, heart failure, mycosis fungoides, prostate cancer, unknown cause, and lymphoma respectively. ESRF occurred in five (15.1%) patients in group 1 (dialysis 3; transplantation, 2) and 17 (17.7%) patients in group 2 (dialysis, 3; transplanta- 
Discussion
In cohorts of patients with IgAN, the proportion of patients over age 50 appears to have increased since 1968. The first studies showed very low percentages of subjects over age 50: 2.3% [5] , 12.1% [6] or a low mean age: 24 years [7] . In more recent studies, the proportions of patients over 50 years of age and mean age have increased: 33.9, 21% [8, 9] , 33, 28 years [10, 11] . In our prospective study, conducted for a short period of time during which policies on renal biopsy and possible environmental factors changed little, we found that 25.5% of subjects were over age 50, and mean age was 38.4 years. These subjects over age 50 that accounted for the fourth and final quartile of our cohort have been compared to the first three quartiles.
The interval between the first symptoms of the disease and histological diagnosis is 4 years, and is the same in subjects both under and over age 50 years. It corresponds to the interval reported by other investigators [6, 7, 11] . According to Bogenschtitz et al., the interval was longer in subjects over age 30 than in those under 30, i.e. 11.4 vs 7.4 years [10] . Our results suggest that IgAN can develop after age 50. But it cannot be ruled out that this disorder can remain quiescent and asymptomatic for many years and only become manifest much later.
In agreement with findings reported in the literature [5, 8, 9] , the majority of our patients were men in all age categories. Among symptoms which revealed the presence of IgAN, gross haematuria occurred with a similar incidence in patients either under or over age 50. This result differs from that reported by other investigators, who found mean age to be 5, 6 and 12 years lower in patients with gross haematuria in comparison to those who did not have this symptom [5, 6, 8] .
Elevated serum levels of IgA are common in IgAN even though they do not affect prognosis [6, 8, 11, 12] . In our study, serum IgA levels were clearly higher in patients over age 50. We may ask whether there is 100 % -50% - increased intestinal permeability in elderly subjects in comparison to younger subjects [15] and whether the mucosa undergoes increased stimulation to produce IgA after age 50 [16] . Also we may question whether the relative undernourishment with resultant hypergammaglobulinaemia observed in very elderly subjects accounts for the discrepancy, which thus would be independent of the underlying renal disorder. Since the exact cause of IgA is controversial [17] , it is difficult to provide a precise answer to these questions. Our study showed a higher incidence of neoplastic disease in the group of patients over 50. The former consisted of carcinomas which, as described elsewhere [18] involved the mucosa of some organs (prostate, colon, larynx). And there is some consensus in recognizing that IgA are partially produced by the mucosa through the intervention of gut-associated lymphoid tissue [16, 17] . In our study, subjects over age 50 were more commonly hypertensive at the onset of IgAN and had significantly higher systolic blood pressure without concomitant elevated diastolic blood pressure at histological diagnosis. This difference seems to be the result of age rather than IgAN. The prevalence of essential hypertension is less than 21% before age 50 and greater 44% after 50 [19] . Moreover, diastolic blood pressure tends to rise with age but the rate of increase is less marked than that for systolic blood pressure and the average value tends to remain stable or decline after the fifth decade [20] . This corresponds to findings in the study conducted by Kusumoto [12] , who showed that the harmful effect of hypertension on renal function was significant in subjects under age 40 but subsequently regressed.
Proteinuria was higher in patients over 50 than in those under 50 but the statistical significance was marginal (P<0.05). Studies on large cohorts of patients, all ages combined, identified high proteinuria as a parameter which carries a poor prognosis [5] [6] [7] [8] [9] [10] [11] . In our study, the prognostic impact of proteinuria may not be apparent because of the relatively short follow-up.
Several investigators [7, 10, 11] have shown that the severity of tubulointerstitial lesions is a better criterion of severity of histological damage than glomerular lesions. D'Amico et al. [6] reported that there is a significant correlation between advanced age and extent of mesangial proliferation, overall glomerular sclerosis, interstitial fibrosis, and vascular damage. In our study, no morphological parameter was characteristic of the patients over age 50 except for endarteritis, which was more common. Vascular lesion, the only difference between the two groups of patients studied, can perhaps be explained by changes in renal histology with age [21] . In patients over age 80, 30% of glomeruli are found to be hyalinized because of sclerosing of preglomerular vessels. Glomerular changes are accompanied by tubular atrophy and because the remaining glomeruli undergo hypertrophy, these lesions cause subclinical injury.
The difference we observed between C cr and serum creatinine may be explained in several different ways. It has been demonstrated that GFR decreases with age. This decrease is very moderate in elderly normotensive subjects [21] and can be amplified by even a slight rise in blood pressure [22] . Furthermore, it is possible that in the group of patients over 50, some of whom had cancer, a decrease in muscle weight and/or malnourishment may account for this difference. The question arises as to whether advanced age at time of diagnosis has any specific impact on prognosis.
Results of different studies are contradictory. For Droz et al. [5] , relative risk of renal failure increases with age at time of onset; but, there may have been a recruitment bias in his study. Indeed, the proportion of patients over 50 years of age was very low (2.3%), and probably corresponds to subjects who had serious renal disease at the time of diagnosis. Neelakantappa et al. [9] and Bogenschutz et al. [10] demonstrated that patients over age 30 have a less favourable prognosis than those under 30. In our opinion, this age limit is not representative of old age. According to D'Amico et al., mean age at onset and at biopsy was slightly higher in patients with an unfavourable prognosis [6] . In contrast, Boyce et al. [8] and especially Alamartine et al. and Beukhof et al. in their multivariate analyses [7, 11] did not demonstrate any unfavourable impact of age on renal function. In our prospective, multicentre study, with a short follow-up, even if the higher incidence of death in elderly subjects is taken into account, analysis of renal survival curves shows that the probability of developing ESRF does not increase after age 50.
